August 7th, 2011
Ablating short-segment Barrett esophagus: What’s your weapon of choice?
The first cases of Barrett esophagus (BE) ablation in the late 1980s used YAG and Argon laser. Since then, a myriad of ablation techniques have been described, including multipolar electrocautery (MPEC), argon plasma coagulation (APC), cryotherapy, radiofrequency ablation (RFA), and endoscopic mucosal resection (EMR). Each technique has had its advocates, and some of the techniques appear to have certain advantages in certain types of BE: e.g., long segment, nodular, etc.
Most cases of BE are short segment, and most neoplastic cases do not have nodules or erosions. So the question I would like to see discussed is: In a patient with 1–2 cm of otherwise featureless flat but neoplastic BE:
What ablation technique would you use, and what do you feel makes this technique advantageous?
What would be your second option, and when would you employ it?
Do you use more than one technique, and, if so, which ones do you use and why?
What are the most common complications you see with BE ablation?
What is your overall success at complete BE elimination?
We look forward to your comments.
Categories: Patient care
Tags: Barrett esophagus
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

M. Brian Fennerty, MD
Editor-in-Chief
NEJM Journal Watch Gastroenterology
Biography | Disclosures | Summaries
Learn more about Gut Check on Gastroenterology.
From NEJM: Recently in Gastroenterology- A New Stage for Seasoned Actors — Food Anaphylaxis and the Cysteinyl Leukotrienes November 20, 2025The author describes two studies implicating intestinally generated cysteinyl leukotrienes in food anaphylaxis.
- Acromegaly November 13, 2025This review updates the pathophysiology and disease course of acromegaly, focusing on the general clinician’s key role in early diagnosis and management.
- A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D November 9, 2025Tobevibart plus elebsiran and tobevibart alone both lowered HDV RNA and ALT levels. The combination resulted in a high incidence of undetectable HDV RNA and an HBsAg level below 10 IU/ml at week 48.
- A New Stage for Seasoned Actors — Food Anaphylaxis and the Cysteinyl Leukotrienes November 20, 2025
-
Tag Cloud
- Ambulatory endoscopy center antiretroviral therapy Barrett esophagus boceprevir bowel preparation CMS colitis colonoscopy colorectal cancer screening CT colonography DDW drug interactions efavirenz endoscopist Endoscopy gastroenterology GI bleeding hepatitis HIV IBS Irritable Bowel Syndrome Medicare midazolam nurse Plavix PPIs primary care probiotics ritonavir Screening colonoscopy sedation sigmoidoscopy telaprevir training virtual colonoscopy
